Incidental pulmonary embolism is often missed on multislice CT, but patients may not fare any worse for the oversight, a German researcher said during a session Monday at the ECR.
Incidental pulmonary embolism is often missed on multislice CT, but patients may not fare any worse for the oversight, a German researcher said during a session Monday at the ECR.
Patients with incidental and therefore untreated PE actually have a more favorable short-term clinical outcome than those who receive treatment, according to a retrospective study conducted at the University of Munich. The research calls into question the value of detecting minor pulmonary embolism on MSCT of the chest.
Researchers examined 2535 consecutive chest MSCT scans in 1966 patients and examined clinical outcomes in the short term (after 30 days) and long term (after one year). They recorded coexisting morbidity, treatment with anticoagulant therapy (ACT), and complications. Results were presented by Dr. Christophe Engelke, a consultant radiologist at the university.
Through independent review of images by radiologists, researchers also identified true positives and false negatives on the original CT scan. Patient notes were reviewed for unsuspected PE. Three radiologist reviewers were required to reach consensus on the image findings.
Out of the study group, 117 (6.6%) were identified as PE positive and file review was completed in 96 of these cases. Of these 96 cases, 63 had active malignancy (77%) and 58 (68%) had unsuspected PE.
PE severity differed significantly between patients who were true positive and those who had a false negative on the CT report, said Engelke. The most severe cases were detected while the minor cases were more likely to be missed.
Of the patients determined to have PE, 49% received anticoagulant therapy. Therapy was not administered in some of the other cases due to contraindications.
Bleeding complications related to the anticoagulant therapy affected seven patients, and included two fatal cases and five major nonfatal hemorrhage cases.
Patients with unsuspected PE and a false negative CT actually had a better survival rate after 30 days than those who were appropriately treated, Engelke said. This was due to bleeding complications and severity of PE, which was an important predictor of survival. Patients with massive PE had a worse outcome in the short term.
Long-term survival was affected mainly by the presence of comorbidity, rather than PE, Engelke said.
Can MRI-Guided Transurethral Ultrasound Ablation Have an Impact for Localized Prostate Cancer?
December 11th 2023Follow-up MRI imaging one year after transurethral ultrasound ablation revealed approximately 50 percent decreases in prostate volume and median PSA density, according to recently presented research findings at the 2023 Society of Urologic Oncology (SUO) Annual Meeting.
What a New Mammography Study Reveals About BMI, Race, Ethnicity and Advanced Breast Cancer Risk
December 8th 2023In a new study examining population attributable risk proportions (PARPs) based on data from over three million screening mammography exams, researchers found that postmenopausal Black women had the highest BMI-related PARP and premenopausal Asian and Pacific Islander women had the highest breast density-related PARP for advanced breast cancer.
Study: Contrast-Enhanced Mammography Changes Surgical Plan in 22.5 Percent of Breast Cancer Cases
December 7th 2023Contrast-enhanced mammography detected additional lesions in 43 percent of patients and led to additional biopsies in 18.2 percent of patients, over half of whom had malignant lesions, according to a study of over 500 women presented at the recent Radiological Society of North America (RSNA) conference.
What a New Study Reveals About Adjunctive DBT and Early-Stage Invasive Breast Cancer
December 6th 2023The combination of digital breast tomosynthesis (DBT) and digital mammography had a 21.6 higher invasive breast cancer detection rate for stage 1 tumors than digital mammography alone, according to a new study involving nearly 100,000 women.